Page last updated: 2024-08-23

nigericin and imiquimod

nigericin has been researched along with imiquimod in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, D; Chen, G; Lin, J; Lin, Y; Liu, A; Luo, T; Ouyang, D; Pan, H; Qin, M; Zhou, X1
Cang, J; Chen, G; He, Q; Wang, C; Wang, Y; Yu, J; Zhong, M1

Other Studies

2 other study(ies) available for nigericin and imiquimod

ArticleYear
Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation.
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Adenine; Adenosine Triphosphate; Anti-Inflammatory Agents; Antioxidants; Arthritis, Gouty; Caspase 1; Humans; Hydrolyzable Tannins; Imiquimod; Inflammasomes; Inflammation; Interleukin-1beta; Lactate Dehydrogenases; Lipopolysaccharides; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleosides; Propidium; Pyroptosis; Reactive Oxygen Species; Uric Acid

2022
Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages
    Frontiers in immunology, 2023, Volume: 14

    Topics: Adenosine Triphosphate; Animals; Imiquimod; Inflammasomes; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Potassium; RNA, Messenger; Sphingosine-1-Phosphate Receptors

2023